Torudokimab
Based on 1 Customer Validation
Torudokimab is a humanized antibody expressed in CHO, targeting IL-33. Torudokimab has a huIgG4SP type heavy chain and a huκ type light chain, with a predicted molecular weight (MW) of 145.22 kDa. The isotype control for Torudokimab can refer to Human IgG4 kappa, Isotype Control (HY-P99003).
For research use only. We do not sell to patients.
- Purity : 99%
- CAS No.: 2241728-76-5
- Molecular Weight:145.22 kDa
-
Storage:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
IL-33
Application
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized His-hu-IL-33-CTD-mutant2 can bind Torudokimab. The EC50 for this effect is 80.86 ng/mL. -
Loaded Torudokimab on ProA biosensor, can bind IL-33 Protein, Human (His, HY-P70475) with an affinity constant of 1.559E-10 M as determined in BLI assay.
Product Details
-
CAS No. 2241728-76-5
-
Accession O95760
-
Molecular Weight 145.22 kDa
-
Species Reactivity
Human
-
Conjugated
Unconjugated
-
Isotype
Human IgG4 kappa
-
Recommend Isotype Controls
-
Format
-
Human IgG4 kappa
-
Product Properties
-
Appearance
Liquid
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Purity
99%
-
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
-
Storage & Stability
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Shipping
Shipping with dry ice.
Purity & Documentation
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)